Project Details
| Status | Active |
|---|---|
| Effective start/end date | 04/9/24 → 10/25/26 |
Funding
- Sanofi US Services Incorporated: $22,161.00
EFC17504 A Randomized Double-blind Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants with Nonrelapsing Secondary Progressive Multiple Sclerosis
- Coyle, Patricia (PI)
- Kowalska, Agnieszka (CoPI)
- Polito, Kelly (CoPI)
- McLinskey, Nancy (CoPI)
- Melville, Patricia (CoPI)
Project: Research